Radiotherapy holds lung tumors at three years

Article

Highly focused stereotactic body radiation therapy can eliminate tumors better than conventional radiotherapy and may improve survival for inoperable non-small cell lung cancer, according to a Radiation Therapy Oncology Group study.

Highly focused stereotactic body radiation therapy can eliminate tumors better than conventional radiotherapy and may improve survival for inoperable non-small cell lung cancer, according to a Radiation Therapy Oncology Group study.

The most exciting aspect of the prospective study was the high rate of primary tumor control-97.6%-at three years, according to Dr. Robert Timmerman, a professor at the University of Texas Southwestern Medical Center in Dallas and principal investigator of the study.

Stereotactic body radiation therapy as delivered in the trial more than doubled the rate of primary tumor control provided by conventional radiotherapy, he said. This suggests the technique could provide a significant step forward in the battle against inoperable non-small cell lung cancer.

The phase II study included 59 patients with biopsy-proven peripheral non-small cell tumors measuring less than 5 cm in diameter with conditions disallowing surgical treatment.

This was the first North American multicenter cooperative group study to test stereotactic body radiation therapy in treating these types of patients. It was published in the March 17 Journal of the American Medical Association.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.